Quest PharmaTech, Inc. (QPT.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 28, 16:00
Quest PharmaTech Net Income (Quarterly) : 3.401M for Jan. 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2026 | 3.401M |
| October 31, 2025 | 1.078M |
| July 31, 2025 | -0.1762M |
| April 30, 2025 | 0.6951M |
| January 31, 2025 | -1.694M |
| October 31, 2024 | 0.0347M |
| July 31, 2024 | 0.7196M |
| April 30, 2024 | -0.8613M |
| January 31, 2024 | -1.979M |
| October 31, 2023 | -0.7601M |
| July 31, 2023 | -0.1722M |
| April 30, 2023 | -0.1069M |
| January 31, 2023 | -4.759M |
| October 31, 2022 | -0.9111M |
| July 31, 2022 | -0.614M |
| April 30, 2022 | -1.048M |
| January 31, 2022 | -75.87M |
| October 31, 2021 | -9.032M |
| July 31, 2021 | 0.4489M |
| April 30, 2021 | -0.5859M |
| January 31, 2021 | 77.03M |
| October 31, 2020 | 3.783M |
| July 31, 2020 | 3.216M |
| April 30, 2020 | 106.04M |
| January 31, 2020 | -4.743M |
| Date | Value |
|---|---|
| October 31, 2019 | -3.354M |
| July 31, 2019 | -2.516M |
| April 30, 2019 | -2.640M |
| January 31, 2019 | -2.075M |
| October 31, 2018 | -1.753M |
| July 31, 2018 | -2.489M |
| April 30, 2018 | -2.329M |
| January 31, 2018 | -3.279M |
| October 31, 2017 | -2.251M |
| July 31, 2017 | -2.107M |
| April 30, 2017 | -1.299M |
| January 31, 2017 | -1.653M |
| October 31, 2016 | -1.394M |
| July 31, 2016 | -1.115M |
| April 30, 2016 | -0.2582M |
| January 31, 2016 | -3.766M |
| October 31, 2015 | -0.2241M |
| July 31, 2015 | -0.50M |
| April 30, 2015 | -0.2505M |
| January 31, 2015 | -0.8571M |
| October 31, 2014 | -0.2672M |
| July 31, 2014 | -0.3131M |
| April 30, 2014 | -0.3834M |
| January 31, 2014 | 1.268M |
| October 31, 2013 | -0.5252M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.8336M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
| Waverley Pharma, Inc. | -0.1437M |
| Goldcoast Resource Corp. | -0.1629M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -3.401M |
| EPS Diluted (Quarterly) | 0.0201 |
| Enterprise Value | 4.368M |
| Earnings Yield | 148.0% |
| Normalized Earnings Yield | 91.50 |